News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
HULL CARL
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/17/2023 |
4
| HULL CARL (CEO) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.
Txns:
| Granted 147,638 shares
@ $0 Granted 270,109 options to buy
@ $15.52, valued at
$4.2M
|
|
06/01/2022 |
4
| HULL CARL (Director) has filed a Form 4 on Ortho Clinical Diagnostics Holdings plc
Txns:
| Disposed/sold 21,011 shares
@ $0 Disposed/sold 41,172 shares
@ $0 |
|
01/27/2022 |
4
| HULL CARL (CEO) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.
Txns:
| Granted 81,600 shares
@ $0 Granted 151,200 options to buy
@ $26.32, valued at
$4M
|
|
05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/27/2021 |
3
| HULL CARL (Director) has filed a Form 3 on Ortho Clinical Diagnostics Holdings plc |
11/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/23/2020 |
4
| HULL CARL (CEO) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.
Txns:
| Granted 60,000 options to buy
@ $27, valued at
$1.6M
|
|
11/19/2020 |
3
| HULL CARL (CEO) has filed a Form 3 on MARAVAI LIFESCIENCES HOLDINGS, INC. |
02/05/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/15/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/02/2012 |
4
| HULL CARL (Chairman and CEO) has filed a Form 4 on GEN PROBE INC
Txns:
| Disposed/sold 47,044 shares
@ $82.75, valued at
$3.9M
Disposed/sold 62,188 options to buy
@ $47.42, valued at
$2.9M
Disposed/sold 35,000 options to buy
@ $60.82, valued at
$2.1M
Disposed/sold 37,500 options to buy
@ $60.15, valued at
$2.3M
Disposed/sold 19,480 options to buy
@ $43.72, valued at
$851.7k
Disposed/sold 105,000 options to buy
@ $42.66, valued at
$4.5M
Disposed/sold 112,500 options to buy
@ $63.8, valued at
$7.2M
Disposed/sold 110,000 options to buy
@ $69.22, valued at
$7.6M
Disposed/sold 10,001 options to buy
@ $0 Disposed/sold 40,000 options to buy
@ $0 |
|
08/02/2012 |
4
| HULL CARL (SVP and GM of Diagnostics) has filed a Form 4 on HOLOGIC INC
Txns:
| Granted 133,333 shares
@ $0 |
|
08/02/2012 |
3
| HULL CARL (SVP and GM of Diagnostics) has filed a Form 3 on HOLOGIC INC |
04/19/2012 |
4
| HULL CARL (Chairman and CEO) has filed a Form 4 on GEN PROBE INC
Txns:
| Sold 5,883 shares
@ $66.23, valued at
$389.6k
Sold 1,200 shares
@ $66.65, valued at
$80k
Exercised 7,083 options to buy
@ $47.42, valued at
$335.9k
|
|
03/20/2012 |
4
| HULL CARL (Chairman and CEO) has filed a Form 4 on GEN PROBE INC
Txns:
| Sold 12,083 shares
@ $66.56, valued at
$804.2k
Exercised 6,354 options to buy
@ $43.72, valued at
$277.8k
Exercised 5,729 options to buy
@ $47.42, valued at
$271.7k
|
|
01/19/2012 |
4
| HULL CARL (Chairman and CEO) has filed a Form 4 on GEN PROBE INC
Txns:
| Sold 17,083 shares
@ $60.859, valued at
$1M
Exercised 17,083 options to buy
@ $43.72, valued at
$746.9k
|
|
08/17/2011 |
4
| HULL CARL (President and CEO) has filed a Form 4 on GEN PROBE INC
Txns:
| Paid exercise price by delivering 1,292 shares
@ $61, valued at
$78.8k
|
|
08/18/2010 |
4
| HULL CARL (President and CEO) has filed a Form 4 on GEN PROBE INC
Txns:
| Paid exercise price by delivering 1,241 shares
@ $47.43, valued at
$58.9k
|
|
03/03/2010 |
4
| HULL CARL (President and CEO) has filed a Form 4 on GEN PROBE INC
Txns:
| Paid exercise price by delivering 840 shares
@ $46.77, valued at
$39.3k
|
|
02/12/2010 |
4
| HULL CARL (President and CEO) has filed a Form 4 on GEN PROBE INC
Txns:
| Granted 105,000 options to buy
@ $42.66, valued at
$4.5M
|
|
08/19/2009 |
4
| HULL CARL (President and CEO) has filed a Form 4 on GEN PROBE INC
Txns:
| Paid exercise price by delivering 1,218 shares
@ $38.51, valued at
$46.9k
|
|
05/20/2009 |
4
| HULL CARL (President and CEO) has filed a Form 4 on GEN PROBE INC
Txns:
| Granted 20,000 shares
@ $0 Granted 55,000 options to buy
@ $43.72, valued at
$2.4M
|
|
03/09/2009 |
4
| HULL CARL (President and COO) has filed a Form 4 on GEN PROBE INC
Txns:
| Paid exercise price by delivering 825 shares
@ $38.96, valued at
$32.1k
|
|
|
|